Team 4- Furling group

Our research is focused on both pathophysiology and biotherapies for Myotonic Dystrophy (DM1), and follows two complementary axes:

  • Deciphering pathophysiologic mechanisms triggered by CUGexp-RNA and involved in :
    • alterations of the motor unit and the muscle function
    • non-muscular features (cardio-vascular….)
  • Development of innovative therapeutic approaches for DM1, and evaluation using cellular and animal models

Group members

Denis FURLING, PhD, DR – CNRS, Team leader
Joëlle MARIE, PhD, DR – Emeritus
Arnaud KLEIN, PhD, CR – INSERM
Frédérique RAU, PhD, CR – INSERM
Alain SUREAU, PhD, CR – INSERM
Ludovic ARANDEL, Msc, IE – AIM
Michel NEY, PhD, IR
Gilles MOULAY, PhD, Post-Doc
Charles FRISON-ROCHE, PhD student
Magdalena MATLOKA, PhD student
Guillaume SGARD, Student

Contact :  denis.furling@sorbonne-universite.fr

 

Relevant publications

Other publications
http://www.ncbi.nlm.nih.gov/pubmed/?term=Furling+D